Tibet Aim Pharm., Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002C39
  • SHE: 002826
CNY
17.39
-0.06 (-0.34%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
177.05
182.58
147.29
177.54
162.91
148.53
139.04
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
177.05
182.58
147.29
177.54
162.91
148.53
139.04
Raw Material Cost
34.55
33.88
28.47
29.71
31.56
31.84
37.39
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.09
0.03
0.16
0.31
0.33
0.20
0.15
Selling and Distribution Expenses
109.61
121.02
100.68
118.35
104.22
101.58
87.84
Other Expenses
0.10
0.05
0.46
0.73
0.07
0.10
0.32
Total Expenditure (Excl Depreciation)
145.27
155.43
133.88
155.64
136.78
134.57
128.58
Operating Profit (PBDIT) excl Other Income
31.8
27.200000000000003
13.4
21.9
26.099999999999998
14
10.5
Other Income
29.60
1.03
3.34
34.70
5.29
10.24
3.42
Operating Profit (PBDIT)
62.45
29.19
16.12
57.87
33.55
26.27
15.67
Interest
0.09
0.03
0.16
0.31
0.33
0.20
0.15
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
142.50
148.70
118.82
147.83
131.35
116.69
101.65
Depreciation
4.25
4.25
4.51
4.51
5.06
5.06
5.35
Profit Before Tax
58.11
24.91
11.45
53.05
28.16
21.01
10.17
Tax
11.08
5.26
0.09
9.03
9.35
2.08
4.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
47.03
19.65
10.82
44.21
18.76
18.79
4.11
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
47.03
19.65
10.82
44.21
18.76
18.79
4.11
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.54
-0.18
0.05
0.13
0.73
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
47.03
19.65
11.36
44.02
18.81
18.93
4.84
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
863.65
838.02
816.02
802.15
764.05
760.83
739.00
Earnings per share (EPS)
0.25
0.1
0.06
0.24
0.1
0.1
0.02
Diluted Earnings per share
0.25
0.1
0.06
0.24
0.1
0.1
0.02
Operating Profit Margin (Excl OI)
16.15%
13.09%
5.61%
10.51%
14.24%
7.39%
4.96%
Gross Profit Margin
35.22%
15.97%
10.84%
32.42%
20.39%
17.55%
11.16%
PAT Margin
26.56%
10.76%
7.34%
24.9%
11.52%
12.65%
2.96%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 8.66% vs -14.98% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 150.00% vs 57.98% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 16.25% vs 58.10% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is -66.67% vs 200.00% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of Tibet Aim Pharm., Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
177.05
0
177.05
Other Operating Income
0.00
0.00
0.00
Total Operating income
177.05
0
177.05
Raw Material Cost
34.55
0
34.55
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.09
0
0.09
Selling and Distribution Expenses
109.61
0
109.61
Other Expenses
0.10
0.00
0.10
Total Expenditure (Excl Depreciation)
145.27
0
145.27
Operating Profit (PBDIT) excl Other Income
31.78
0.00
31.78
Other Income
29.60
0
29.60
Operating Profit (PBDIT)
62.45
0
62.45
Interest
0.09
0
0.09
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
142.50
0
142.50
Depreciation
4.25
0
4.25
Profit Before Tax
58.11
0
58.11
Tax
11.08
0
11.08
Provisions and contingencies
0
0
0.00
Profit After Tax
47.03
0
47.03
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
47.03
0
47.03
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
47.03
0
47.03
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
863.65
0
863.65
Earnings per share (EPS)
0.25
0
0.25
Diluted Earnings per share
0.25
0
0.25
Operating Profit Margin (Excl OI)
16.15%
0%
0.00
16.15%
Gross Profit Margin
35.22%
0%
0.00
35.22%
PAT Margin
26.56%
0%
0.00
26.56%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 17.70 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -3.07% vs 23.96% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 8.66% vs -14.98% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.70 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 139.80% vs 71.93% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 150.00% vs 57.98% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.29 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 16.67% vs 120.31% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 16.25% vs 58.10% in Jun 2025

Quarterly - Interest
Interest 0.01 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 0.00% vs -100.00% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -66.67% vs 200.00% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.15%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025